198 related articles for article (PubMed ID: 30469360)
1. Virulence of Marburg Virus Angola Compared to Mt. Elgon (Musoke) in Macaques: A Pooled Survival Analysis.
Blair PW; Keshtkar-Jahromi M; Psoter KJ; Reisler RB; Warren TK; Johnston SC; Goff AJ; Downey LG; Bavari S; Cardile AP
Viruses; 2018 Nov; 10(11):. PubMed ID: 30469360
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.
Cross RW; Fenton KA; Geisbert JB; Ebihara H; Mire CE; Geisbert TW
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S258-70. PubMed ID: 26092858
[TBL] [Abstract][Full Text] [Related]
3. Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.
Fernando L; Qiu X; Melito PL; Williams KJ; Feldmann F; Feldmann H; Jones SM; Alimonti JB
J Infect Dis; 2015 Oct; 212 Suppl 2():S234-41. PubMed ID: 25957966
[TBL] [Abstract][Full Text] [Related]
4. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
5. Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.
Nicholas VV; Rosenke R; Feldmann F; Long D; Thomas T; Scott DP; Feldmann H; Marzi A
J Infect Dis; 2018 Nov; 218(suppl_5):S458-S465. PubMed ID: 30215737
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
Daddario-DiCaprio KM; Geisbert TW; Geisbert JB; Ströher U; Hensley LE; Grolla A; Fritz EA; Feldmann F; Feldmann H; Jones SM
J Virol; 2006 Oct; 80(19):9659-66. PubMed ID: 16973570
[TBL] [Abstract][Full Text] [Related]
7. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
Woolsey C; Geisbert JB; Matassov D; Agans KN; Borisevich V; Cross RW; Deer DJ; Fenton KA; Eldridge JH; Mire CE; Geisbert TW
J Infect Dis; 2018 Nov; 218(suppl_5):S582-S587. PubMed ID: 29939296
[TBL] [Abstract][Full Text] [Related]
8. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.
Geisbert TW; Daddario-DiCaprio KM; Geisbert JB; Young HA; Formenty P; Fritz EA; Larsen T; Hensley LE
J Infect Dis; 2007 Nov; 196 Suppl 2(Suppl 2):S372-81. PubMed ID: 17940973
[TBL] [Abstract][Full Text] [Related]
9. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.
Thi EP; Mire CE; Ursic-Bedoya R; Geisbert JB; Lee ACH; Agans KN; Robbins M; Deer DJ; Fenton KA; MacLachlan I; Geisbert TW
Sci Transl Med; 2014 Aug; 6(250):250ra116. PubMed ID: 25143366
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus.
Qiu X; Wong G; Audet J; Cutts T; Niu Y; Booth S; Kobinger GP
J Virol; 2014 Nov; 88(21):12703-14. PubMed ID: 25142608
[TBL] [Abstract][Full Text] [Related]
11. Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure.
Johnston SC; Lin KL; Twenhafel NA; Raymond JL; Shamblin JD; Wollen SE; Wlazlowski CB; Wilkinson ER; Botto MA; Goff AJ
PLoS One; 2015; 10(9):e0138843. PubMed ID: 26413900
[TBL] [Abstract][Full Text] [Related]
12. Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence Between Angola and Ci67 Strains.
Cross RW; Fenton KA; Foster SL; Geisbert JB; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S559-S570. PubMed ID: 37610176
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a guinea pig model for Marburg virus.
Wong G; Cao WG; He SH; Zhang ZR; Zhu WJ; Moffat E; Ebihara H; Embury-Hyatt C; Qiu XG
Zool Res; 2018 Jan; 39(1):32-41. PubMed ID: 29511143
[TBL] [Abstract][Full Text] [Related]
14. Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques.
Alves DA; Glynn AR; Steele KE; Lackemeyer MG; Garza NL; Buck JG; Mech C; Reed DS
Vet Pathol; 2010 Sep; 47(5):831-51. PubMed ID: 20807825
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a mouse model for Marburg hemorrhagic fever.
Warfield KL; Bradfute SB; Wells J; Lofts L; Cooper MT; Alves DA; Reed DK; VanTongeren SA; Mech CA; Bavari S
J Virol; 2009 Jul; 83(13):6404-15. PubMed ID: 19369350
[TBL] [Abstract][Full Text] [Related]
16. Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques.
Lin KL; Twenhafel NA; Connor JH; Cashman KA; Shamblin JD; Donnelly GC; Esham HL; Wlazlowski CB; Johnson JC; Honko AN; Botto MA; Yen J; Hensley LE; Goff AJ
J Virol; 2015 Oct; 89(19):9875-85. PubMed ID: 26202230
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing.
Zumbrun EE; Garvey CB; Wells JB; Lynn GC; Van Tongeren S; Steffens JT; Wetzel KS; Gomba LM; O'Brien KA; Rossi FD; Zeng X; Lee ED; Raymond JLW; Hoffman DA; Jay AN; Brown ES; Kallgren PA; Norris SL; Cantey-Kiser J; Kudiya H; Arthur C; Blair C; Babusis D; Chu VC; Singh B; Bannister R; Porter DP; Cihlar T; Dye JM
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140576
[TBL] [Abstract][Full Text] [Related]
18. A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.
Marzi A; Banadyga L; Haddock E; Thomas T; Shen K; Horne EJ; Scott DP; Feldmann H; Ebihara H
Sci Rep; 2016 Dec; 6():39214. PubMed ID: 27976688
[TBL] [Abstract][Full Text] [Related]
19. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).
Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S
Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636
[TBL] [Abstract][Full Text] [Related]
20. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
Front Immunol; 2018; 9():3071. PubMed ID: 30723475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
